300246.SZ WACC - Weighted Average Cost of Capital

The WACC of Guangdong Biolight Meditech Co Ltd (300246.SZ) is 9.1%.

The Cost of Equity of Guangdong Biolight Meditech Co Ltd (300246.SZ) is 10.80%.

The Cost of Debt of Guangdong Biolight Meditech Co Ltd (300246.SZ) is 5.00%.

	Range	Selected
Cost of equity	9.40% - 12.20%	10.80%
Tax rate	12.70% - 14.40%	13.55%
Cost of debt	5.00% - 5.00%	5.00%
WACC	8.1% - 10.1%	9.1%

WACC

300246.SZ WACC calculation

Category	Low	High

Long-term bond rate	2.7%	3.2%
Equity market risk premium	6.1%	7.1%
Adjusted beta	1.1	1.19

Additional risk adjustments	0.0%	0.5%
Cost of equity	9.40%	12.20%

Tax rate	12.70%	14.40%
Debt/Equity ratio	0.36	0.36
Cost of debt	5.00%	5.00%

After-tax WACC	8.1%	10.1%


Selected WACC	9.1%

300246.SZ's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 300246.SZ:

cost_of_equity (10.80%) = risk_free_rate (2.95%) + equity_risk_premium (6.60%) * adjusted_beta (1.1) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.